Renal denervation for hypertension management in the UK: a Delphi expert consensus
Peter Alexander John Haworth, Clare Bent, Neil Chapman, Rasha Kadem Al-Lamee, Indranil Dasgupta, Terry McCormack, Kazem Rahimi · 2026
Read Renal denervation for hypertension management in the UK: a Delphi expert consensus by Peter Alexander John Haworth, Clare Bent, Neil Chapman, Rasha Kadem Al-Lamee, Indranil Dasgupta, Terry McCormack, Kazem Rahimi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13479678.txt.
Description
BackgroundRenal denervation (RDN) has emerged as a guideline-recommended therapeutic option in hypertension management with several high-quality, randomised, placebo-controlled trials demonstrating efficacy and safety. However, the lack of expert consensus on patient selection for RDN in the UK has led to debate regarding its use.
Catalog record
| CREATOR | Peter Alexander John Haworth, Clare Bent, Neil Chapman, Rasha Kadem Al-Lamee, Indranil Dasgupta, Terry McCormack, Kazem Rahimi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |